Early Lung Cancer Diagnosis by Biosensors
AbstractLung cancer causes an extreme threat to human health, and the mortality rate due to lung cancer has not decreased during the last decade. Prognosis or early diagnosis could help reduce the mortality rate. If microRNA and tumor-associated antigens (TAAs), as well as the corresponding autoantibodies, can be detected prior to clinical diagnosis, such high sensitivity of biosensors makes the early diagnosis and prognosis of cancer realizable. This review provides an overview of tumor-associated biomarker identifying methods and the biosensor technology available today. Laboratorial researches utilizing biosensors for early lung cancer diagnosis will be highlighted. View Full-Text
Share & Cite This Article
Zhang, Y.; Yang, D.; Weng, L.; Wang, L. Early Lung Cancer Diagnosis by Biosensors. Int. J. Mol. Sci. 2013, 14, 15479-15509.
Zhang Y, Yang D, Weng L, Wang L. Early Lung Cancer Diagnosis by Biosensors. International Journal of Molecular Sciences. 2013; 14(8):15479-15509.Chicago/Turabian Style
Zhang, Yuqian; Yang, Dongliang; Weng, Lixing; Wang, Lianhui. 2013. "Early Lung Cancer Diagnosis by Biosensors." Int. J. Mol. Sci. 14, no. 8: 15479-15509.